221 related articles for article (PubMed ID: 30212566)
1. Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri.
Zhou W; Debnath A; Jennings G; Hahn HJ; Vanderloop BH; Chaudhuri M; Nes WD; Podust LM
PLoS Pathog; 2018 Sep; 14(9):e1007245. PubMed ID: 30212566
[TBL] [Abstract][Full Text] [Related]
2. CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM).
Debnath A; Calvet CM; Jennings G; Zhou W; Aksenov A; Luth MR; Abagyan R; Nes WD; McKerrow JH; Podust LM
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006104. PubMed ID: 29284029
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA Reductase Inhibitors as Drug Leads against
Hahn HJ; Abagyan R; Podust LM; Roy S; Ali IKM; Debnath A
ACS Chem Neurosci; 2020 Oct; 11(19):3089-3096. PubMed ID: 32881478
[TBL] [Abstract][Full Text] [Related]
4. Differential Growth Rates and
Russell AC; Kyle DE
Microbiol Spectr; 2022 Feb; 10(1):e0189921. PubMed ID: 35138140
[TBL] [Abstract][Full Text] [Related]
5. Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.
Debnath A; Tunac JB; Galindo-Gómez S; Silva-Olivares A; Shibayama M; McKerrow JH
Antimicrob Agents Chemother; 2012 Nov; 56(11):5450-7. PubMed ID: 22869574
[TBL] [Abstract][Full Text] [Related]
6. Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.
Zyserman I; Mondal D; Sarabia F; McKerrow JH; Roush WR; Debnath A
Exp Parasitol; 2018 May; 188():36-41. PubMed ID: 29551628
[TBL] [Abstract][Full Text] [Related]
7. Amphotericin B induces apoptosis-like programmed cell death in Naegleria fowleri and Naegleria gruberi.
Cárdenas-Zúñiga R; Silva-Olivares A; Villalba-Magdaleno JA; Sánchez-Monroy V; Serrano-Luna J; Shibayama M
Microbiology (Reading); 2017 Jul; 163(7):940-949. PubMed ID: 28721850
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide identification of pathogenicity factors of the free-living amoeba Naegleria fowleri.
Zysset-Burri DC; Müller N; Beuret C; Heller M; Schürch N; Gottstein B; Wittwer M
BMC Genomics; 2014 Jun; 15(1):496. PubMed ID: 24950717
[TBL] [Abstract][Full Text] [Related]
9. The anti-amoebic activity of Pinus densiflora leaf extract against the brain-eating amoeba Naegleria fowleri.
Lê HG; Kim W; Kang JM; Võ TC; Yoo WG; Cheong H; Na BK
Parasites Hosts Dis; 2024 May; 62(2):169-179. PubMed ID: 38835258
[TBL] [Abstract][Full Text] [Related]
10. Primary Amoebic Meningoencephalitis by
Güémez A; García E
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572533
[No Abstract] [Full Text] [Related]
11. In silico analysis of Naegleria fowleri cathepsin B paralogs: important drug targets.
Aurongzeb M; Haq SA; Rashid Y; Ahmed Naqvi SH; Hussain SI; Rehman AU; Kaleem I; Bashir S
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3162-3172. PubMed ID: 33928602
[TBL] [Abstract][Full Text] [Related]
12. Sterol biosynthesis via cycloartenol and other biochemical features related to photosynthetic phyla in the amoeba Naegleria lovaniensis and Naegleria gruberi.
Raederstorff D; Rohmer M
Eur J Biochem; 1987 Apr; 164(2):427-34. PubMed ID: 3569274
[TBL] [Abstract][Full Text] [Related]
13. Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba.
Tillery L; Barrett K; Goldstein J; Lassner JW; Osterhout B; Tran NL; Xu L; Young RM; Craig J; Chun I; Dranow DM; Abendroth J; Delker SL; Davies DR; Mayclin SJ; Calhoun B; Bolejack MJ; Staker B; Subramanian S; Phan I; Lorimer DD; Myler PJ; Edwards TE; Kyle DE; Rice CA; Morris JC; Leahy JW; Manetsch R; Barrett LK; Smith CL; Van Voorhis WC
PLoS One; 2021; 16(3):e0241738. PubMed ID: 33760815
[TBL] [Abstract][Full Text] [Related]
14. Identification and molecular typing of Naegleria fowleri from a patient with primary amebic meningoencephalitis in China.
Zhang LL; Wu M; Hu BC; Chen HL; Pan JR; Ruan W; Yao LN
Int J Infect Dis; 2018 Jul; 72():28-33. PubMed ID: 29751112
[TBL] [Abstract][Full Text] [Related]
15. Comparative Genomic and Transcriptomic Analysis of Naegleria fowleri Clinical and Environmental Isolates.
Joseph SJ; Park S; Kelley A; Roy S; Cope JR; Ali IKM
mSphere; 2021 Aug; 6(4):e0063721. PubMed ID: 34378985
[TBL] [Abstract][Full Text] [Related]
16. Virtual Screening of Alkaloid and Terpenoid Inhibitors of SMT Expressed in
Abraham J; Chauhan N; Ray S
Molecules; 2022 Sep; 27(17):. PubMed ID: 36080504
[TBL] [Abstract][Full Text] [Related]
17. Identification of Four Amoebicidal Nontoxic Compounds by a Molecular Docking Screen of
Shi D; Chahal KK; Oto P; Nothias LF; Debnath A; McKerrow JH; Podust LM; Abagyan R
ACS Infect Dis; 2019 Dec; 5(12):2029-2038. PubMed ID: 31583882
[No Abstract] [Full Text] [Related]
18. Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review.
Jahangeer M; Mahmood Z; Munir N; Waraich UE; Tahir IM; Akram M; Ali Shah SM; Zulfqar A; Zainab R
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):199-212. PubMed ID: 31612525
[TBL] [Abstract][Full Text] [Related]
19. Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads.
Debnath A
Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1099-1106. PubMed ID: 33496193
[No Abstract] [Full Text] [Related]
20. Excretory and Secretory Proteins of Naegleria fowleri Induce Inflammatory Responses in BV-2 Microglial Cells.
Lee J; Kang JM; Kim TI; Kim JH; Sohn HJ; Na BK; Shin HJ
J Eukaryot Microbiol; 2017 Mar; 64(2):183-192. PubMed ID: 27480446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]